Professor Brent L. Iverson is a University Distinguished Teaching Professor, and the head of The University of Texas at Austin’s School of Undergraduate Studies.

His work straddles the line between organic chemistry and molecular biology. His company has patented various innovations, including a late-stage anthrax treatment that has been authorised by the FDA.